Early research (Phase 1)Study completedNCT01015014
What this trial is testing
Safety, Pharmacokinetics (PK) and Tolerability Study of a Novel Drug for Treatment of Bacterial Infections
Who this might be right for
Gram-negative Bacterial Infection
Pfizer 64